These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 3315188)
21. In vivo antitumor activity of cis-bis-neodecanoato-trans-R,R-1, 2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes. Mori A; Wu SP; Han I; Khokhar AR; Perez-Soler R; Huang L Cancer Chemother Pharmacol; 1996; 37(5):435-44. PubMed ID: 8599866 [TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of liposomes containing a lipophilic cisplatin derivative for clinical use. Perez-Soler R; Francis K; al-Baker S; Pilkiewicz F; Khokhar AR J Microencapsul; 1994; 11(1):41-54. PubMed ID: 8138874 [TBL] [Abstract][Full Text] [Related]
23. Cellular accumulation and DNA damage induced by liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum+ ++(II) in LoVo and LoVo/PDD cells. Han I; Nguyen T; Yang LY; Khokhar AR; Perez-Soler R Anticancer Drugs; 1994 Feb; 5(1):64-8. PubMed ID: 8186432 [TBL] [Abstract][Full Text] [Related]
24. [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line]. Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Mitsui H; Koizumi K; Matsuno T Gan To Kagaku Ryoho; 1990 Jan; 17(1):73-8. PubMed ID: 2404458 [TBL] [Abstract][Full Text] [Related]
25. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer. Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673 [TBL] [Abstract][Full Text] [Related]
26. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes. Khokhar AR; al-Baker S; Shamsuddin S; Siddik ZH J Med Chem; 1997 Jan; 40(1):112-6. PubMed ID: 9016335 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane. Anderson WK; Quagliato DA; Haugwitz RD; Narayanan VL; Wolpert-DeFilippes MK Cancer Treat Rep; 1986 Aug; 70(8):997-1002. PubMed ID: 3731155 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II). Macquet JP; Cros S; Armand JP Cancer Res; 1984 Sep; 44(9):3736-43. PubMed ID: 6540142 [TBL] [Abstract][Full Text] [Related]
29. Ultrastructural and freeze fracture localization of multilamellar liposomes containing a lipophilic cisplatin analogue in normal tissues and liver metastases of M5076 reticulosarcoma. Perez-Soler R; Khokhar AR; Lautersztain J; Mitchell PA; Schmidt KL Cancer Drug Deliv; 1987; 4(2):75-88. PubMed ID: 3322541 [TBL] [Abstract][Full Text] [Related]
30. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex. Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175 [TBL] [Abstract][Full Text] [Related]
31. Anthracycline antibiotics with high liposome entrapment: structural features and biological activity. Perez-Soler R; Priebe W Cancer Res; 1990 Jul; 50(14):4260-6. PubMed ID: 2194651 [TBL] [Abstract][Full Text] [Related]
32. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes. Hrubisko M; Balázová E; Kiss F; Kovácová J; Ujházy V Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869 [TBL] [Abstract][Full Text] [Related]
33. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A. Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice. Kido Y; Khokhar AR; Yoshida M; Thai GW; Siddik ZH Drug Metab Dispos; 1994; 22(2):312-7. PubMed ID: 8013287 [TBL] [Abstract][Full Text] [Related]
35. Toxicity and efficacy studies on a series of lipid-soluble dineodecanoato(trans-R,R- and trans-S,S-1,2-diaminocyclohexane) platinum (II) complexes entrapped in liposomes. Khokhar AR; al-Baker S; Perez-Soler R Anticancer Drugs; 1992 Apr; 3(2):95-100. PubMed ID: 1525398 [TBL] [Abstract][Full Text] [Related]
36. Cell death and DNA fragmentation induced by liposomal platinum(II) complex, L-NDDP in A2780 and A2780/PDD cells. Han I; Ling YH; Khokhar AR; Perez-Soler R Anticancer Res; 1994; 14(2A):421-6. PubMed ID: 8017841 [TBL] [Abstract][Full Text] [Related]
37. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy. Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926 [TBL] [Abstract][Full Text] [Related]
38. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631 [TBL] [Abstract][Full Text] [Related]
39. Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles. Verschraegen CF; Kumagai S; Davidson R; Feig B; Mansfield P; Lee SJ; Maclean DS; Hu W; Khokhar AR; Siddik ZH J Cancer Res Clin Oncol; 2003 Oct; 129(10):549-55. PubMed ID: 14513369 [TBL] [Abstract][Full Text] [Related]
40. Drug resistance induction and cross-resistance studies with Pt-complexes. Hrubisko M; Balázová E; Ujházy V Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]